AATMAJ (AATMAJ) fundamentals

AATMAJ is a listed company, part of the Healthcare Services sector, listed on the NSE as AATMAJ (ISIN INE0OB201016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.

What AATMAJ does

Aatmaj Healthcare Limited is an India-based company, which provides comprehensive hospital services. The Company’s principal activities include the operation of multidisciplinary private hospitals and clinics. The Company has units, namely Jupiter Hospital and group of JTP Hospitals. Its services and facilities include Invasive, Neurology, Neurosurgery, Nephrology, anesthesiology, orthopedics, neonatology services, ultrasound, dermatology, radiology, surgery, critical care medicine, 3D-4D sonography, urology care, modular operation theatres, joint replacement unit, echocardiography, pathology laboratory, and digital X-ray. It owns hospitals such as Jambusar General Hospital and JTP Sardar Patel with bed capacity of approximately 150 beds. It is associated with companies, organizations, universities and institutes providing regular healthcare check-up facilities for their employees and their post-graduation students.

Valuation and market data

Last close₹18.15
Market capitalisation₹40 crore
Enterprise value₹38 crore
P/E (TTM)3.92
Price to book0.79
Price to sales (TTM)0.46
Book value per share₹22.91
Dividend yield0.00%
SectorHealthcare Services
Industry

Annual results

PeriodRevenueProfit before taxNet profitEPS
Mar 2026₹25 crore₹1 crore₹1 crore0.32
Mar 2025₹21 crore₹1 crore₹1 crore0.28
Mar 2024₹17 crore₹1 crore₹1 crore0.39
Mar 2023₹27 crore₹8 crore₹6 crore3.64
Mar 2022₹22 crore₹7 crore₹5 crore37.41

Figures are as reported (standalone), in ₹ crore.

Shareholding pattern

As of Mar 2026:

Promoters64.3%
Foreign institutions (FII)0.0%
Mutual funds0.0%
Other domestic institutions0.0%
Retail and others35.7%

More on BreakPoint

FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.

Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.